Statistics
Publications
21
Citations
3.2K
H-Index
20
Active since
1989
A Levitzki is an author at Hebrew University of Jerusalem specializing in tyrosine kinase inhibitors, life sciences, and receptor tyrosine kinase signaling.
Publications per year
1989–2004
21
21
Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor
Naftaly Meydan, T Grunberger, Harjit Dadi et al. · Nature · 1996 · 912 citations
Flk-1 as a target for tumor growth inhibition.
L M Strawn, Gerald McMahon, Harald App et al. · PubMed · 1996 · 318 citations
Medicine, Oncology, Pharmacology +15
1–5 of 21